To assess the antiviral efficacy of lamivudine ( LAM ) , entecavir ( ETV ) , telbivudine ( LDT ) , and lamivudine and adefovir dipivoxil ( CLA ) combination in previously untreated hepatitis B patients at different time points during a @-week treatment period .